Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cellular and Molecular Life Sciences | journal | 2.371 Q1 | 261 | 609 | 1072 | 57651 | 9683 | 1062 | 8.35 | 94.67 | 44.70 |  |
| 2 | Vaccines | journal | 1.655 Q1 | 85 | 2178 | 2497 | 113547 | 18817 | 2435 | 7.81 | 52.13 | 47.41 | |
| 3 | Inflammation Research | journal | 1.339 Q1 | 107 | 124 | 309 | 7988 | 2054 | 294 | 6.69 | 64.42 | 43.14 | |
| 4 | Frontiers in Pharmacology | journal | 1.064 Q1 | 154 | 5709 | 7742 | 369866 | 44134 | 7564 | 5.39 | 64.79 | 45.29 | |
| 5 | EJNMMI Radiopharmacy and Chemistry | journal | 0.972 Q1 | 28 | 33 | 97 | 1487 | 488 | 92 | 4.50 | 45.06 | 29.70 | |
| 6 | Inflammopharmacology | journal | 0.932 Q1 | 68 | 188 | 379 | 12130 | 1989 | 367 | 5.27 | 64.52 | 44.07 | |
| 7 | Medical Cannabis and Cannabinoids | journal | 0.713 Q2 | 13 | 16 | 38 | 725 | 164 | 32 | 4.20 | 45.31 | 34.67 | |
| 8 | PharmacoEconomics - Open | journal | 0.646 Q2 | 20 | 74 | 197 | 3026 | 419 | 183 | 2.28 | 40.89 | 45.88 | |
| 9 | Current Pharmacology Reports | journal | 0.638 Q2 | 35 | 36 | 100 | 3139 | 453 | 96 | 5.59 | 87.19 | 41.73 | |
| 10 | Chemotherapy | journal | 0.627 Q2 | 61 | 29 | 106 | 1048 | 310 | 100 | 3.41 | 36.14 | 40.18 | |
| 11 | Pharmacology | journal | 0.551 Q2 | 67 | 64 | 238 | 2539 | 637 | 230 | 2.85 | 39.67 | 44.04 | |
| 12 | Skin Pharmacology and Physiology | journal | 0.534 Q3 | 86 | 35 | 102 | 1593 | 282 | 101 | 2.61 | 45.51 | 41.57 | |
| 13 | Journal of Xenobiotics | journal | 11 | 27 | 15 | 2408 | 100 | 15 | 6.71 | 89.19 | 54.81 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data